Double Medical Technology

Double Medical Technology P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Double Medical Technology (002901.SZ) as of Nov 5, 2026 is 26.04. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 105.73 — a change of -75.38% (lower).

P/FCF

26.04

YoY

-75.38%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Double Medical Technology is 2025 26.04 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Double Medical Technology was 2024 105.73 . It decreases by -75.38% lower compared to the previous year.

The Double Medical Technology P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
78.48 CNY
Jan 1, 2019
158.55 CNY
Jan 1, 2020
43.40 CNY
Jan 1, 2021
41.47 CNY
Jan 1, 2022
-116.00 CNY
Jan 1, 2023
-78.37 CNY
Jan 1, 2024
105.73 CNY
Jan 1, 2025
26.04 CNY
The Double Medical Technology P/FCF history
YEARP/FCFYoY
26.04-75.38%
105.73-234.91%
-78.37-32.44%
-116.00-379.74%
41.47-4.45%
43.40-72.63%
158.55+102.02%
78.48+17.42%
66.84-36.07%
104.55-73.01%
387.28+50.02%
258.15—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Double Medical Technology Stock analysis

What does Double Medical Technology do? Double Medical Technology Inc, listed on the Shenzhen Stock Exchange under ticker 002901.SZ, operates in the Health Care sector with a focus on medical consumables. Headquartered in Xiamen, China, the company employs 3,793 full-time staff. It completed its initial public offering (IPO) on September 22, 2017. Double Medical Technology engages in the production, research and development, and sale of medical consumables, including orthopedic trauma implant materials, spinal implant materials, and nerve surgical implant materials. The company also manufactures surgical instruments. Its products are distributed both domestically within China and internationally. The firm's website is http://www.double-medical.com/. As a publicly traded entity, it provides medical products essential for surgical procedures and patient care, operating within the healthcare industry framework. The company's operations are centered around the development and supply of specialized medical devices and consumables, targeting healthcare providers and institutions globally. Double Medical Technology maintains a presence in both domestic and international markets, reflecting its strategic approach to market expansion and product distribution. Double Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Double Medical Technology stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Double Medical Technology is 26.04 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Double Medical Technology changed from 105.73 to 26.04, representing a -75.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Double Medical Technology since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Double Medical Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Double Medical Technology

All Key Metrics — Double Medical Technology